Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 1.0 | 5.0 |
Min SIP Amount | ₹99 | ₹100 |
Expense Ratio | 1.75 | 1.67 |
NAV | ₹25.51 | ₹214.64 |
Fund Started | 23 Apr 2019 | 20 Aug 2004 |
Fund Size | ₹8286.63 Cr | ₹15520.74 Cr |
Exit Load | Exit load of 1% if redeemed within 1 year. | Exit load of 1% if redeemed within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 18.17% | 25.70% |
3 Year | 8.84% | 24.45% |
5 Year | 16.66% | 22.61% |
1 Year
3 Year
5 Year
Equity | 94.45% | 83.32% |
Cash | 5.55% | 16.35% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.21% |
Infosys Ltd. | 8.28% |
ICICI Bank Ltd. | 7.15% |
Axis Bank Ltd. | 5.22% |
One97 Communications Ltd. | 5.15% |
Sapphire Foods India Ltd. | 3.94% |
Bharti Airtel Ltd. | 3.75% |
SKF India Ltd. | 3.32% |
KPIT Technologies Ltd. | 3.30% |
Mphasis Ltd. | 3.24% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.49% |
ICICI Bank Ltd. | 9.21% |
Axis Bank Ltd. | 8.35% |
Maruti Suzuki India Ltd. | 4.46% |
SBI Life Insurance Company Ltd. | 4.17% |
Cipla Ltd. | 4.15% |
Kotak Mahindra Bank Ltd. | 3.98% |
HCL Technologies Ltd. | 3.81% |
Bharti Airtel Ltd. | 3.67% |
Piramal Pharma Ltd. | 3.64% |
Name | Gaurav Misra | Dhruv Muchhal |
Start Date | 31 Jan 2019 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation/income by investing in equity & equity related instruments of up to 30 companies. | The scheme seeks to generate long term capital appreciation/income by investing in equity & equity related instruments of up to 30 companies. |
Launch Date | 23 Apr 2019 | 20 Aug 2004 |
Description
Launch Date